Abstract
The moderate impairment of cell-mediated immunity that occurs in pregnancy justifies concern when a pregnant woman develops influenza. We treated a woman for influenza pneumonia with respiratory failure at 33 weeks' gestation with oral amantadine and ribavirin inhalation therapy in conjunction with evacuation of the uterus and delivery.
MeSH terms
-
Adult
-
Amantadine / therapeutic use*
-
Drug Therapy, Combination
-
Female
-
Humans
-
Infant, Newborn
-
Influenza A virus / isolation & purification
-
Influenza, Human / drug therapy*
-
Pneumonia, Viral / drug therapy*
-
Pregnancy
-
Pregnancy Complications, Infectious / drug therapy*
-
Pregnancy Outcome
-
Ribavirin / therapeutic use*
-
Ribonucleosides / therapeutic use*
Substances
-
Ribonucleosides
-
Ribavirin
-
Amantadine